ALFA Finder| Revenue growth | 18.5% YoY for Q4 FY26; 20% for full year FY26. |
|---|---|
| Margins | EBITDA margin at ~34-35%; seeing non-linear growth vs headcount. |
| Order book | Announced significant full platform deal with a mid-sized health system. |
| Demand visibility | Strong; 90% repeat revenue; top 10 clients have 5+ year vintage. |
| Management confidence | High confidence in 'True North' strategy and AI-driven competitive moat. |
Growth
FY26 revenue reached INR 3,193 cr (up 20%), EBITDA INR 1,091 cr (up 38%), and PAT INR 721 cr (up 48%).
Outlook
Targeting FY30 EBITDA of INR 3,000 cr; shifting TruBridge from COBOL to SQL; scaling MyCare Hub and Scribble Select AI.
Risks
Seasonal Q4 weakness in US healthcare; potential pricing deflation in commoditized point solutions; TruBridge integration and debt deleveraging.
Earnings Call filed with NSE, NSE: IKS. Summary written with AI assistance from the document.
Inventurus Knowledge Solutions Ltd: key numbers
- Share price
- ₹1,660.20
- Market cap
- ₹28,485 Cr
- Revenue (annual)
- ₹3,192 Cr
- Net profit (annual)
- ₹721.5 Cr
- P/E (TTM)
- 35.6×Sector 54.5×
- Promoter holding
- 63.72%+0.00% QoQ
- FII holding
- 8.10%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Inventurus Knowledge Solutions Ltd
All →Inventurus Knowledge Solutions Acquisition Worth ₹4.65 Cr
Inventurus Knowledge Solutions' US subsidiary acquired 100% of Turbo Health Holdings, LLC for USD 500,000. The deal, worth ₹4.65 Crore, expands market reach in healthcare technology.
- Value
- ₹4.65 Cr
Inventurus Knowledge Solutions Earnings Call Transcript: Key Takeaways
Revenue ₹1,592 Cr (+104% YoY, mostly TrueBridge consolidation) and EBITDA ₹442 Cr (~28%). Legacy IKS grew ~13% in USD. TrueBridge is flat for FY27, and management gives no growth guidance.
Inventurus Knowledge Solutions Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 15,925 mn (+103.9% YoY) with TruBridge consolidated for 82 days. Reported EBITDA margin 27.7%; PAT INR 2,176 mn (+20.4% YoY); adjusted PAT INR 2,734 mn.
Inventurus Knowledge Solutions Results Update
IKS Health reported strong Q2 FY27 revenue and EBITDA growth year-on-year, with TruBridge integration adding scale. The release also highlighted new US healthcare customer wins.
Inventurus Knowledge Solutions Q2 FY27 Results: Net Profit ₹213.4 Cr, Up 18.1% YoY
Inventurus Knowledge Solutions Ltd reported revenue from operations of ₹1,592 Cr (+103.9% YoY) and net profit of ₹213.4 Cr (+18.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹213.4 Cr · +18.1% YoY
Inventurus Knowledge Solutions Board Meeting Date
Inventurus Knowledge Solutions will hold a board meeting on 05 November 2026 to consider September 2026 results. This advance notice reports no approved results yet.